Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay C Strum

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Pharmacology and Experimental Therapeutics|October 12, 2004
GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in ratsLihong Chen, Baichun Yang, Judi A McNulty, et al.
Science Translational Medicine|April 28, 2017
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustionShenghui He, Patrick J Roberts, Jessica A Sorrentino, et al.
Molecular Cancer Research : MCR|February 18, 2017
CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPCJames P Stice, Suzanne E Wardell, John D Norris, et al.
PPAR Research|October 21, 2011
Rosiglitazone Induces Mitochondrial Biogenesis in Differentiated Murine 3T3-L1 and C3H/10T1/2 AdipocytesJames X Rong, Jean-Louis D Klein, Yang Qiu, et al.
Breast Cancer Research and Treatment|March 5, 2020
G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancerKaitlyn J Andreano, Suzanne E Wardell, Jennifer G Baker, et al.
Diabetes|November 21, 2007
Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese menUlf Risérus, Dennis Sprecher, Tony Johnson, et al.
The Journal of Biological Chemistry|December 24, 2002
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acidsCelia P Briscoe, Mohammad Tadayyon, John L Andrews, et al.
The Journal of Biological Chemistry|December 24, 2002
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acidsAndrew J Brown, Susan M Goldsworthy, Ashley A Barnes, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Pharmacology and Experimental Therapeutics|October 12, 2004
GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in ratsLihong Chen, Baichun Yang, Judi A McNulty, et al.
Science Translational Medicine|April 28, 2017
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustionShenghui He, Patrick J Roberts, Jessica A Sorrentino, et al.
Molecular Cancer Research : MCR|February 18, 2017
CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPCJames P Stice, Suzanne E Wardell, John D Norris, et al.
PPAR Research|October 21, 2011
Rosiglitazone Induces Mitochondrial Biogenesis in Differentiated Murine 3T3-L1 and C3H/10T1/2 AdipocytesJames X Rong, Jean-Louis D Klein, Yang Qiu, et al.
Breast Cancer Research and Treatment|March 5, 2020
G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancerKaitlyn J Andreano, Suzanne E Wardell, Jennifer G Baker, et al.
Diabetes|November 21, 2007
Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese menUlf Risérus, Dennis Sprecher, Tony Johnson, et al.
The Journal of Biological Chemistry|December 24, 2002
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acidsCelia P Briscoe, Mohammad Tadayyon, John L Andrews, et al.
The Journal of Biological Chemistry|December 24, 2002
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acidsAndrew J Brown, Susan M Goldsworthy, Ashley A Barnes, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Pageof 2